Clinical presentation of Kawasaki disease

Progress in Pediatric Cardiology

Volumn 6, Issue 3, 1997, Pages 193-201

  Mason, Wilbert H ^a   Burns, Jane C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Complications; Diagnosis; Differential diagnosis; Kawasaki disease

Indexed keywords

ALLERGIC REACTION; ARTICLE; CERVICAL LYMPH NODE; CHILD; CLINICAL FEATURE; CONJUNCTIVA DISEASE; CORONARY ARTERY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; FEVER; HUMAN; INFANT; LIMB; LIP; LYMPHADENOPATHY; MEASLES; MOUTH CAVITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; RASH; SCARLET FEVER; SYMPTOM;

EID: 0030893539     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(97)00190-2     Document Type: Article

References (60)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Japan J Allerg 1967;16:178-222.
2. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanajawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatr 1974;54:271-276.
3. Dajani AS, Taubert KA, Gerber MA et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-1780.
4. Melish ME, Hicks RM, Larson EJ. Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 1976;130:599-607.
5. Rauch AM. Kawasaki syndrome: issues in etiology and treatment. Adv Pediatr Infect Dis 1989;4:163-182.
6. Jackson JL, Kunkel MR, Lebow L, Gates RH. Adult Kawasaki disease report of two cases treated with intravenous gamma globulin. Arch Intern Med 1994;154:1398-1405.
7. Melish ME. Kawasaki syndrome: a new infectious disease? J Infect Dis 1981;143:317-324.
8. Fink CW. A perineal rash in Kawasaki disease. Pediatr Infect Dis 1983;2:140-141.
9. Urbach AH, McGregor RS, Malatack JJ, Gartner JC, Zetelli BJ. Kawasaki disease and perineal rash. Am J Dis Child 1988; 142:1174-1176.
10. Krowchuk DP, Bass J, Elgart GW. Kawasaki disease with an exanthem limited to the diaper area. Amer J Dis Child 1988;142:1136-1137.
11. Kim JJ, Shulman ST. Lymphadenitis as dominant presenting manifestation of Kawasaki disease. In: Takahashi M, Taubert K, editors. Proceedings of the Fourth International Symposium on Kawasaki Disease. Dallas; American Heart Association, 1993;39-41.
12. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med 1995;149:779-783.
13. Mason WH, Takahashi M, Schneider T. Recurrence of Kawasaki disease in a large urban cohort in the United States. In: Takahashi M, Taubert K, editors. Proceedings of the Fourth International Symposium on Kawasaki Disease. Dallas; American Heart Association 1993;39-41.
14. Newburger JW, Takahashi M, Beiser AS et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-1639.
15. Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan S.D. Left ventricular contractility and function in Kawasaki syndrome. Circulation 1989;79:1237-1246.
16. Akagi T, Kato H, Inoue O, Sato N, Imamura K. Valvular heart disease in Kawasaki syndrome: incidence and natural history. Am Heart J 1990;120:366-371.
17. Suddleson EA, Reid B, Woolley MM, Takahashi M. Hydrops of the gallbladder associated with Kawasaki syndrome. J Pediatr Surg 1987;22:956-959.
18. Murphy DJ, Morrow R, Harberg FJ, Hawkins EP. Small bowel obstruction as a complication of Kawasaki disease. Clin Pediatr 1987;26:193-196.
19. Miyake T, Kawamori J, Yoshida T, Nakano H, Kohno S, Ohba S. Small bowel pseudo-obstruction in Kawasaki disease. Pediatr Rad 1987;17:383-386.
20. Lanting WA, Muinos WI, Kamani NR. Pancreatitis heralding Kawasaki disease. 1992;121:743-744.
21. Melish ME. Kawasaki Syndrome: A 1986 perspective. Rheum Dis Clinics of North America 1987;13:341-347.
22. Hicks RV, Melish ME. Kawasaki syndrome: rheumatic complaints and analysis of salicylate therapy. Arthr Rheum 1979;22:621.
23. Burns JC, Joffe L, Sargent RA, Glode MP. Anterior uveitis associated with Kawasaki syndrome. Pediatr Infect Dis J 1985;4:258-261.
24. Smith LBH, Newburger JW, Burns JC. Kawasaki syndrome and the eye. Pediatr Infect Dis J 1989;8:116-118.
25. Burns JC, Wright JD, Newburger JW, Schneeberger EE, Mierau GW, Smith LE. Conjunctival biopsy in patients with Kawasaki disease, Pediatr Pathol Labor Med 1995;15:547-553.
26. Kabani A, Joffe A, LeMay M, Jadavji T. Testicular findings early in Kawasaki disease. In: Takahashi M, Taubert K, editors. Proceedings of the Fourth International Symposium on Kawasaki Disease. American Heart Association Press, 1993.
27. Watanabe J, Kawasaki T, Takemura T. Study on cerebrospinal fluid cellular morphology in mucocutaneous lymph node syndrome. Acta Paed Jap (in Japanese) 1980;84:1259-1263.
28. Teresawa K, Ichinose E, Matsuishi T, Kato H. Neurological complication in Kawasaki disease. Brain Dev 1983;5:371-374.
29. Sundel RP, Cleveland SS, Beiser AS et al. Audiologic profiles of children with Kawasaki disease. Am J Otology 1992;13:512-515.
30. Brosius CL, Newburger JW, Burns JC, Hojnowski-Diaz P, Zierler S, Leung DYM. Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr Infect Dis J 1988;7:863-866.
31. Koutras AK. Myositis with mucoeutaneous lymph node syndrome. NY State Med J 1980;80:1138-1139.
32. Tomita S, Chung K, Mas M, Gidding S, Shulman ST. Peripheral gangrene associated with Kawasaki disease. Clin Infect Dis 1992;12:121-126.
33. Krieger I, Prough AJ. Raynaud's phenomenon in an infant. J Pediatr 1972;80:145-151.
34. Burns JC, Mason WH, Glode MP et al. Clinical and epidemiological characteristics of patients referred for evaluation of possible Kawasaki disease. J Pediatr 1991;143:317-324
35. Burns JC, Glode MP, Clarke AH, Wiggins J, Hathawav WE. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms. J Pediatr 1984;105:206-211
36. Ohta K, Seno A, Shintani N et al. Increased levels of urinary interleukin-6 in Kawasaki disease. Eur J Pediatr 1993;152:647-649.
37. Eberhard BA, Anderson U, Laxer RM, Rose V, Silverman ED. Evaluation of the cytokine response in Kawasaki disease. Pediatr Infect Dis J 1995;14:199-203.
38. Matsubara T, Furukawa S, Yabuta K. Serum levels of TNF, IL-2 receptor, and interferon-γ in Kawasaki disease involved coronary artery lesions. Clin Immunol Immunopathol 1990;56:29-36.
39. Leung DYM, Siegel RL, Grady S et al. Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immun Immunopath 1982;23:100-112.
40. Furukawa S, Matsubara T, Motohashi T, Nakachi S, Sasai K, Yabuta K. Expression of CD23 on peripheral blood macrophages/monocytes in Kawasaki disease. Clin Immunol Immunopathol 1990;56:280-286.
41. Wong M, Silverman E, Fish E. Evidence of RANTES, MCP-1, and MIP-1β expression in Kawasaki disease. In press.
42. Newburger JW, Burns JC, Beiser AS, Loscalzo J. A tered lipid profile after Kawasaki syndrome. Circulation 1991;84:625-631.
43. Tanaka N. Kawasaki disease (acute febrile infantile mucocutaneous lymph node syndrome) in Japan: relationship with infantile periarteritis nodosa. Path Microbiol 1975;43:204-218.
44. Landing BH, Larson EJ. Are infantile periarteritis nodosa with coronary involvement and fatal mucocutaneous lymph node syndrome the same?: comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics 1977;59:651-662.
45. Bowyer S, Mason WH, McCurdy DK, Takahashi M. Polyarteritis nodosa (PAN) with coronary aneurysms: the Kawasaki-PAN controversy revisited. J Rheumatol 1994;21:1585.
46. Melekian B. Kawasaki-like infectiuos mononucleosis. Acta Paediatr Scand 1982;71:843-844.
47. Everett D. Mucocutaneous lymph node syndrome (Kawasaki disease) in adults. JAMA 1979;242:542-543.
48. Stern MN, Brown EW, McCurdy D, Lehman TJA. Confusion of poststreptococcal syndrome complicated by uveitis with mucocutaneous lymph node syndrome. Ann Ophthamol 1985;17:259-261.
49. Humphrey T, Sanders S, Stadius M. Leptospirosis mimicking MLNS. J Pediatr 1977;91:853-854.
50. Bergeson PS, Schoenike SL. Mucocutaneous lymph node syndrome: a case masquerading as Rocky Mountain spotted fever. JAMA 1977;237:2299-2302.
51. Yersinia pseudotuberculosis infection in children, resembling Izumi fever and Kawasaki syndrome. Pediatr Infect Dis 1983;2:123-126.
52. Bauman C, Cron RQ, Sherry DD, Francis JS. Reiter syndrome initially misdiagnosed as Kawasaki disease. J Pediatr 1996;366-368.
53. Anderson VM, Bauer HM, Kelly AP. Mucocutaneous lymphnode syndrome in an adult receiving diphenyl-hydantoin. Cutis 1979;23:493-496.
54. Hicks RA, Murphy JV, Jackson MA. Kawasaki-like syndrome caused by carbamazepine. Pediatr Infect Dis J 1988;7:525-526.
55. Adler R, Boxstein D, Schaff P, Kelly D. Metallic mercury vapor poisoning simulating mucocutaneous lymph node syndrome. J Pediatr 1982;101:967-968.
56. Orlowski JP, Mercer RD. Urine mercury levels in Kawasaki disease. Pediatrics 1980;66:633-636.
57. Rowley AH, Gonzaliz-Crussi F, Gidding SS, Duffy E, Shulman ST. Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 1987;110:409-413.
58. Burns JC, Wiggins JW, Toews WH, Newburger JW, Leung DYM, Wilson H, Glode MP. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 1986;109:759-763.
59. Levy M, Koren G. Atypical Kawasaki disease: analysis of clinical presentation and diagnostic clues. Pediatr Infect Dis J 1990;9:122-126.
60. Boven K, DeGraeff-Meeder ER, Spliet W, Kuis W. Atypical Kawasaki disease: an often missed diagnosis. Eur J Pediatr 1992;151:577-580.